enGene grants 195,000 stock options to officer

enGene Holdings Inc. reported a new stock option grant to its Chief Legal Officer and Corporate Secretary, Lee G. Giguere.

Rhea-AI Filing Summary

enGene Holdings Inc. reported a new stock option grant to its Chief Legal Officer and Corporate Secretary, Lee G. Giguere. On 01/30/2026, Giguere received a stock option for 195,000 common shares with an exercise price of $9.53, reported as held directly.

The option was granted at no cost and is structured to vest monthly in substantially equal amounts over 48 months, subject to Giguere’s continued service with the company. After this grant, Giguere beneficially owned 195,000 stock options tied to enGene common shares.

Insider Trade Summary

Grant/Award: 195,000 shares

Grant/Award 1 txn

Insider Giguere Lee

Role Chief Legal Ofc. and Corp Secy

Type	Security	Shares	Price	Value
Grant/Award	Stock Option (Right to Buy)	195,000	$0.00	$0.00

Holdings After Transaction: Stock Option (Right to Buy) — 195,000 contracts (Direct)

Footnotes (1)

1. F1. This option vests monthly in substantially equal amounts for 48 months, subject to the reporting person's continued service.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did enGene (ENGN) report for Lee G. Giguere?

enGene reported a grant of stock options to Chief Legal Officer and Corporate Secretary Lee G. Giguere. On 01/30/2026, he received options to purchase 195,000 common shares at an exercise price of $9.53, with the award reported as held directly.

How many enGene (ENGN) stock options were granted in this Form 4?

The Form 4 shows a single grant of stock options covering 195,000 common shares. These derivative securities give the holder the right to buy enGene common shares at an exercise price of $9.53, subject to the award’s vesting schedule and other terms.

What is the exercise price and term of the enGene (ENGN) stock options?

The reported stock option has an exercise price of $9.53 per common share. According to the filing, the option expires on 01/30/2036, providing a long-dated right to purchase 195,000 common shares if the vesting and other conditions are satisfied.

How do the enGene (ENGN) stock options for Lee G. Giguere vest?

The filing explains that the option vests monthly in substantially equal amounts over 48 months. Vesting is conditioned on Giguere’s continued service with enGene, meaning he earns the right to exercise additional portions of the option each month over four years.

Is the enGene (ENGN) stock option grant to Lee G. Giguere direct or indirect ownership?

The Form 4 identifies the ownership of the stock option as direct. Following the 01/30/2026 grant, Giguere beneficially owned 195,000 derivative securities, all reported under direct ownership, tied to an equivalent number of enGene common shares upon exercise.

What role does the reporting person hold at enGene (ENGN) in this Form 4?

The reporting person, Lee G. Giguere, serves as Chief Legal Officer and Corporate Secretary of enGene Holdings Inc. The reported 195,000-share stock option grant represents part of his compensation package in his capacity as a senior officer of the company.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 02/03/2026 - 04:12 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Giguere Lee

(Last) (First) (Middle)

C/O 4868 RUE LEVY, SUITE 220

(Street)

SAINT-LAURENT A8 H4R 2P1

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
enGene Holdings Inc. [ ENGN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	Chief Legal Ofc. and Corp Secy

3. Date of Earliest Transaction (Month/Day/Year)
01/30/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Stock Option (Right to Buy)	$9.53	01/30/2026		A		195,000		(1)	01/30/2036	Common Shares	195,000	$0	195,000	D

Explanation of Responses:

1. This option vests monthly in substantially equal amounts for 48 months, subject to the reporting person's continued service.

	/s/ Lee G. Giguere	02/03/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.